- Market Realist•1 hour ago
As cardiovascular diseases cost the global society around $600 billion annually, this segment is a huge growth opportunity for the pharmaceutical industry.
Two failed acquisitions have cast a long shadow on Sanofi's prospects.
- Motley Fool•yesterday
Cancer drug costs routinely eclipse the six-figure mark, but the prices of these cancer drugs are truly eye-popping.
SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||39.42 - 39.88|
|52 Week Range||36.81 - 44.50|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||23.09|
|Dividend & Yield||1.66 (4.12%)|
|1y Target Est||N/A|